McLelland J, Broadbent V, Yeomans E, Malone M, Pritchard J
Department of Haematology and Oncology, Hospital for Sick Children, London.
Arch Dis Child. 1990 Mar;65(3):301-3. doi: 10.1136/adc.65.3.301.
Fifty eight children with Langerhans cell histiocytosis who were referred to this hospital between 1980 and 1987 were studied. Fourteen had single system disease, and 44 had multisystem disease, of whom 22 had vital organ dysfunction. A conservative approach to treatment was adopted, and when systemic treatment was indicated a short course of prednisolone was used first. Eight of the patients with single system disease required no treatment, while six received local treatment alone. Eight of the patients with multisystem disease did not require systemic treatment, 17 were given prednisolone alone, and 19 were given cytotoxic drugs. Of the 14 with single system disease 13 had no long term after effects. Eight of the patients with multisystem disease died, 24 had long term after effects, and 12 had none. Outcome was related to age and Lahey score. These results compare favourably with other series in which more aggressive approaches were used, and support our conservative approach to treatment.
对1980年至1987年间转诊至我院的58例朗格汉斯细胞组织细胞增多症患儿进行了研究。14例为单系统疾病,44例为多系统疾病,其中22例存在重要器官功能障碍。采用保守治疗方法,当需要进行全身治疗时,首先使用短疗程泼尼松龙。14例单系统疾病患者中,8例无需治疗,6例仅接受局部治疗。44例多系统疾病患者中,8例无需全身治疗,17例仅给予泼尼松龙,19例给予细胞毒性药物。14例单系统疾病患者中,13例无长期后遗症。多系统疾病患者中,8例死亡,24例有长期后遗症,12例无后遗症。预后与年龄和拉希评分有关。这些结果与采用更积极治疗方法的其他系列研究相比更有利,并支持我们的保守治疗方法。